Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy
- 31 December 1995
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 28 (4) , 281-290
- https://doi.org/10.1016/0166-3542(95)00066-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adultsAntimicrobial Agents and Chemotherapy, 1995
- AciclovirDrugs, 1994
- Review of research leading to new anti-herpesvirus agents in clinical development: Valaciclovir hydrochloride (256u, the L-valyl ester of acyclovir) and 882c, a specific agent for varicella zoster virusJournal of Medical Virology, 1993
- Metabolic disposition of BW 256U87, the l-valyl ester of acyclovir, in the rat : T. C. Burnette and P. de Miranda. Burroughs Wellcome Co., Research Triangle Park, NC 27709, USAAntiviral Research, 1992
- Treatment of resistant herpes simplex virus with continuous-infusion acyclovirPublished by American Medical Association (AMA) ,1990
- AcyclovirDrugs, 1989
- Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1988
- Synthesis and antiviral activity of water-soluble esters of acyclovir [9-[(2-hydroxyethoxy)methyl]guanine)Journal of Medicinal Chemistry, 1983
- Clinical Pharmacokinetics of AcyclovirClinical Pharmacokinetics, 1983
- In vitro susceptibility of varicella-zoster virus to acyclovirAntimicrobial Agents and Chemotherapy, 1980